Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    B-cell chronic lymphocytic leukemia was added to the list of conditions described on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:51.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision labels updated from v3.4.3 to v3.5.0. No visible changes to study details, eligibility criteria, or outcomes.
    Difference
    0.0%
    Check dated 2026-03-19T05:25:54.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:47.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added. The funding-lapse notice and the prior Revision: v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:26.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's status was added, with guidance to refer to opm.gov for updates; the page revision label was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:21:42.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Glossary toggle added; capitalization adjusted for labels (e.g., ‘Last Update Submitted that Met QC Criteria’ and ‘No FEAR Act Data’); revision updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:13:59.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.